📋 Tender Overview
Contract awarded for Announcement for a commissioned order based on article 266a, paragraph 5, item 3 of the law on medicinal products for human medicine, in connection with article 1, paragraph 1, item 2, article 3, paragraph 3, article 15b, paragraph 1 and article 15v, paragraph 1 of regulation no. 10/17.11.2011 of the ministry of health. lot-0001, title: announcement for the awarded contract based on article 266a, paragraph 5, item 3 of the law on medicinal products for human medicine, in connection with article 1, paragraph 1, item 2, article 3, paragraph 3, article 15b, paragraph 1 and article 15v of regulation no. 10/17.11.2011 of the ministry of health, description: the contractor agrees, after receiving a letter of consent from the executive agency for medicines (eam) and a written request for delivery of the medicinal product specified below, to deliver the following medicinal product, in the quantities prescribed by umbalsm 'n. i. pirogov' ead with protocol - appendix no. 1 or no. 2 (whichever is applicable), issued in accordance with regulation no. 10 / 17.11.2011, based on the offer of the contractor. international non-proprietary name: phytomenadione (kanavit) trade name: nednadione-k10 pharmaceutical form: 10 mg/ml -1ml, ampoule quantity: 3000 pieces; the contractor agrees, after receiving a letter of consent from the executive agency for medicines (eam) and a written request for delivery, to deliver the following medicinal product with the trade name - nednadione-k10 in the quantities prescribed by umbalsm 'n. i. pirogov' ead with protocol - appendix no. 1 or no. 2 (whichever is applicable), issued in accordance with regulation no. 10 / 17.11.2011, based on the offer of the contractor. estimated value excluding vat: 2000.00 eur.Announcement for a commissioned order based on article 266a, paragraph 5, item 3 of the law on medicinal products for human medicine, in connection with article 1, paragraph 1, item 2, article 3, paragraph 3, article 15b, paragraph 1 and article 15v, paragraph 1 of regulation no. 10/17.11.2011 of the ministry of health.
